Name | elpamotide |
---|---|
Synonyms |
L-Isoleucine, L-arginyl-L-phenylalanyl-L-valyl-L-prolyl-L-α-aspartylglycyl-L-asparaginyl-L-arginyl-
S68632MB2G L-Arginyl-L-phenylalanyl-L-valyl-L-prolyl-L-α-aspartylglycyl-L-asparaginyl-L-arginyl-L-isoleucine 9318 elpamotide |
Description | Elpamotide is an epitope peptide derived from VEGFR2. Elpamotide induces cytotoxic T lymphocytes (CTLs) to kill VEGFR2-expressing endothelial cells. Elpamotide has potential immunostimulatory and antineoplastic activities. Elpamotide can be used in the research of cancer, such as pancreatic cancer[1][2]. |
---|---|
Related Catalog | |
In Vitro | Elpamotide shows potent and specific cytotoxicity in cytotoxic T lymphocytes (CTLs) (4-hour 51Cr-release assay) [1]. |
Density | 1.5±0.1 g/cm3 |
---|---|
Molecular Formula | C47H76N16O13 |
Molecular Weight | 1073.206 |
Exact Mass | 1072.577759 |
LogP | -0.97 |
Index of Refraction | 1.661 |